SCHEMBL125003

SCHEMBL125003

COC1=CC(=O)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL9807679 0.91 MAPT (0.51)
SCHEMBL450333 0.84
SCHEMBL31955606 0.84 MAPT (0.44)
SCHEMBL8101389 0.78 MAPT (0.55)
SCHEMBL10912378 0.78 MAPT (0.41)
SCHEMBL99907 0.78 KMT2A (0.49)
SCHEMBL2600439 0.78 MAPT (0.44)
SCHEMBL2736522 0.76 MAPT (0.40)
SCHEMBL2566463 0.76 MAPT (0.46)
SCHEMBL11694300 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260053932-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS INC (US) 2026-02-26 US disclosed
US-12428423-B2 1H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitor SHENGKE PHARMACEUTICALS (JIANGSU) LTD. (CN) 2025-09-30 US disclosed
US-12419960-B2 Compounds and methods for the targeted degradation of androgen receptor and associated methods of use ARVINAS OPERATIONS, INC. (US) 2025-09-23 US disclosed
US-20250127903-A1 SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2025-04-24 US disclosed
US-12048747-B2 Substituted piperidine Degronimers for Target Protein degradation C4 THERAPEUTICS, INC. (US) 2024-07-30 US disclosed
CN-116783179-A Compounds and methods for targeted degradation of androgen receptor proteins 阿尔维纳斯运营股份有限公司 2023-09-19 CN disclosed
EP-4232445-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN Arvinas Operations, Inc. (US) 2023-08-30 EP disclosed
US-20230084249-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2023-03-16 US disclosed
US-20220315584-A1 1H-IMIDAZO[4,5-H]QUINAZOLINE COMPOUND AS PROTEIN KINASE INHIBITOR SHENGKE PHARMACEUTICALS (JIANGSU) LTD. (CN) 2022-10-06 US disclosed
US-20220315584-A1 1H-IMIDAZO[4,5-H]QUINAZOLINE COMPOUND AS PROTEIN KINASE INHIBITOR SHENGKE PHARMACEUTICALS (JIANGSU) LTD. (CN) 2022-10-06 US disclosed
EP-0003253-B1 HEXAHYDROAZEPINE, PIPERIDINE AND PYRROLIDINE DERIVATIVES AND PROCESSES FOR MAKING AND USING THEM JOHN WYETH &amp; BROTHER LIMITED (GB) 1982-12-22 EP disclosed
US-4306097-A 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents PFIZER INC. (US) 1981-12-15 US disclosed
EP-0021552-A1 Hexahydroazepine, piperidine and pyrrolidine derivatives and processes for preparing them JOHN WYETH &amp; BROTHER LIMITED (GB) 1981-01-07 EP disclosed
US-4197241-A Hexahydroazepine, piperidine and pyrrolidine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1980-04-08 US disclosed
US-4197239-A Hexahydroazepine, piperidine and pyrrolidine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1980-04-08 US disclosed
EP-0003738-A1 Process for producing cyclohexane-1,3-diones or 3-alkoxy-2-cyclohexenones MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1979-09-05 EP disclosed
EP-0003253-A1 Hexahydroazepine, piperidine and pyrrolidine derivatives and processes for making and using them JOHN WYETH &amp; BROTHER LIMITED (GB) 1979-08-08 EP disclosed
US-4058666-A INSECTICIDE ZOECON CORPORATION (US) 1977-11-15 US disclosed
US-4006188-A Cycloalkenones ZOECON CORPORATION (US) 1977-02-01 US disclosed
US-4000174-A NOVEL COMPOUNDS ZOECON CORPORATION (US) 1976-12-28 US disclosed